Skip to main content
The EMBO Journal logoLink to The EMBO Journal
. 1997 Jan 15;16(2):267–280. doi: 10.1093/emboj/16.2.267

The glucocorticoid receptor is a key regulator of the decision between self-renewal and differentiation in erythroid progenitors.

O Wessely 1, E M Deiner 1, H Beug 1, M von Lindern 1
PMCID: PMC1169634  PMID: 9029148

Abstract

During development and in regenerating tissues such as the bone marrow, progenitor cells constantly need to make decisions between proliferation and differentiation. We have used a model system, normal erythroid progenitors of the chicken, to determine the molecular players involved in making this decision. The molecules identified comprised receptor tyrosine kinases (c-Kit and c-ErbB) and members of the nuclear hormone receptor superfamily (thyroid hormone receptor and estrogen receptor). Here we identify the glucocorticoid receptor (GR) as a key regulator of erythroid progenitor self-renewal (i.e. continuous proliferation in the absence of differentiation). In media lacking a GR ligand or containing a GR antagonist, erythroid progenitors failed to self-renew, even if c-Kit, c-ErbB and the estrogen receptor were activated simultaneously. To induce self-renewal, the GR required the continuous presence of an activated receptor tyrosine kinase and had to cooperate with the estrogen receptor for full activity. Mutant analysis showed that DNA binding and a functional AF-2 transactivation domain are required for proliferation stimulation and differentiation arrest. c-myb was identified as a potential target gene of the GR in erythroblasts. It could be demonstrated that delta c-Myb, an activated c-Myb protein, can functionally replace the GR.

Full Text

The Full Text of this article is available as a PDF (530.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amylon M. D., Perrine S. P., Glader B. E. Prednisone stimulation of erythropoiesis in leukemic children during remission. Am J Hematol. 1986 Oct;23(2):179–181. doi: 10.1002/ajh.2830230213. [DOI] [PubMed] [Google Scholar]
  2. Bartůnek P., Pichlíková L., Stengl G., Boehmelt G., Martin F. H., Beug H., Dvorák M., Zenke M. Avian stem cell factor (SCF): production and characterization of the recombinant His-tagged SCF of chicken and its neutralizing antibody. Cytokine. 1996 Jan;8(1):14–20. doi: 10.1006/cyto.1996.0003. [DOI] [PubMed] [Google Scholar]
  3. Baxter J. D., Forsham P. H. Tissue effects of glucocorticoids. Am J Med. 1972 Nov;53(5):573–589. doi: 10.1016/0002-9343(72)90154-4. [DOI] [PubMed] [Google Scholar]
  4. Beato M., Herrlich P., Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell. 1995 Dec 15;83(6):851–857. doi: 10.1016/0092-8674(95)90201-5. [DOI] [PubMed] [Google Scholar]
  5. Beug H., Müllner E. W., Hayman M. J. Insights into erythroid differentiation obtained from studies on avian erythroblastosis virus. Curr Opin Cell Biol. 1994 Dec;6(6):816–824. doi: 10.1016/0955-0674(94)90050-7. [DOI] [PubMed] [Google Scholar]
  6. Beug H., Palmieri S., Freudenstein C., Zentgraf H., Graf T. Hormone-dependent terminal differentiation in vitro of chicken erythroleukemia cells transformed by ts mutants of avian erythroblastosis virus. Cell. 1982 Apr;28(4):907–919. doi: 10.1016/0092-8674(82)90070-8. [DOI] [PubMed] [Google Scholar]
  7. Beug H., Schroeder C., Wessely O., Deiner E., Meyer S., Ischenko I. D., Hayman M. J. Transformation of erythroid progenitors by viral and cellular tyrosine kinases. Cell Growth Differ. 1995 Aug;6(8):999–1008. [PubMed] [Google Scholar]
  8. Billat C. L., Felix J. M., Jacquot R. L. In vitro and in vivo regulation of hepatic erythropoiesis by erythropoietin and glucocorticoids in the rat fetus. Exp Hematol. 1982 Jan;10(1):133–140. [PubMed] [Google Scholar]
  9. Bonde B. G., Sharif M., Privalsky M. L. Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function. J Virol. 1991 Apr;65(4):2037–2046. doi: 10.1128/jvi.65.4.2037-2046.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Boumpas D. T., Chrousos G. P., Wilder R. L., Cupps T. R., Balow J. E. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med. 1993 Dec 15;119(12):1198–1208. doi: 10.7326/0003-4819-119-12-199312150-00007. [DOI] [PubMed] [Google Scholar]
  11. Briegel K., Lim K. C., Plank C., Beug H., Engel J. D., Zenke M. Ectopic expression of a conditional GATA-2/estrogen receptor chimera arrests erythroid differentiation in a hormone-dependent manner. Genes Dev. 1993 Jun;7(6):1097–1109. doi: 10.1101/gad.7.6.1097. [DOI] [PubMed] [Google Scholar]
  12. Caldenhoven E., Liden J., Wissink S., Van de Stolpe A., Raaijmakers J., Koenderman L., Okret S., Gustafsson J. A., Van der Saag P. T. Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol. 1995 Apr;9(4):401–412. doi: 10.1210/mend.9.4.7659084. [DOI] [PubMed] [Google Scholar]
  13. Casini T., Graf T. Bicistronic retroviral vector reveals capacity of v-erbA to induce erythroleukemia and to co-operate with v-myb. Oncogene. 1995 Sep 21;11(6):1019–1026. [PubMed] [Google Scholar]
  14. Cavaillès V., Dauvois S., L'Horset F., Lopez G., Hoare S., Kushner P. J., Parker M. G. Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J. 1995 Aug 1;14(15):3741–3751. doi: 10.1002/j.1460-2075.1995.tb00044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chan H. S., Saunders E. F., Freedman M. H. Diamond-Blackfan syndrome. I. Erythropoiesis in prednisone responsive and resistant disease. Pediatr Res. 1982 Jun;16(6):474–476. doi: 10.1203/00006450-198206000-00014. [DOI] [PubMed] [Google Scholar]
  16. Chan H. S., Saunders E. F., Freedman M. H. Diamond-Blackfan syndrome. II. In vitro corticosteroid effect on erythropoiesis. Pediatr Res. 1982 Jun;16(6):477–478. doi: 10.1203/00006450-198206000-00015. [DOI] [PubMed] [Google Scholar]
  17. Chang T. J., Scher B. M., Waxman S., Scher W. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation. Mol Endocrinol. 1993 Apr;7(4):528–542. doi: 10.1210/mend.7.4.8502237. [DOI] [PubMed] [Google Scholar]
  18. Chiba H., Muramatsu M., Nomoto A., Kato H. Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor. Nucleic Acids Res. 1994 May 25;22(10):1815–1820. doi: 10.1093/nar/22.10.1815. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  20. Clarke M. F., Kukowska-Latallo J. F., Westin E., Smith M., Prochownik E. V. Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol. 1988 Feb;8(2):884–892. doi: 10.1128/mcb.8.2.884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Cole T. J., Blendy J. A., Monaghan A. P., Krieglstein K., Schmid W., Aguzzi A., Fantuzzi G., Hummler E., Unsicker K., Schütz G. Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes Dev. 1995 Jul 1;9(13):1608–1621. doi: 10.1101/gad.9.13.1608. [DOI] [PubMed] [Google Scholar]
  22. Dolznig H., Bartunek P., Nasmyth K., Müllner E. W., Beug H. Terminal differentiation of normal chicken erythroid progenitors: shortening of G1 correlates with loss of D-cyclin/cdk4 expression and altered cell size control. Cell Growth Differ. 1995 Nov;6(11):1341–1352. [PubMed] [Google Scholar]
  23. Espinás M. L., Roux J., Pictet R., Grange T. Glucocorticoids and protein kinase A coordinately modulate transcription factor recruitment at a glucocorticoid-responsive unit. Mol Cell Biol. 1995 Oct;15(10):5346–5354. doi: 10.1128/mcb.15.10.5346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Golde D. W., Bersch N., Cline M. J. Potentiation of erythropoiesis in vitro by dexamethasone. J Clin Invest. 1976 Jan;57(1):57–62. doi: 10.1172/JCI108269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Graf T. Two types of target cells for transformation with avian myelocytomatosis virus. Virology. 1973 Aug;54(2):398–413. doi: 10.1016/0042-6822(73)90152-9. [DOI] [PubMed] [Google Scholar]
  26. Grässer F. A., Graf T., Lipsick J. S. Protein truncation is required for the activation of the c-myb proto-oncogene. Mol Cell Biol. 1991 Aug;11(8):3987–3996. doi: 10.1128/mcb.11.8.3987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Hayman M. J., Meyer S., Martin F., Steinlein P., Beug H. Self-renewal and differentiation of normal avian erythroid progenitor cells: regulatory roles of the TGF alpha/c-ErbB and SCF/c-kit receptors. Cell. 1993 Jul 16;74(1):157–169. doi: 10.1016/0092-8674(93)90303-8. [DOI] [PubMed] [Google Scholar]
  28. Helmberg A., Auphan N., Caelles C., Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J. 1995 Feb 1;14(3):452–460. doi: 10.1002/j.1460-2075.1995.tb07021.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hu Y. L., Ramsay R. G., Kanei-Ishii C., Ishii S., Gonda T. J. Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domain. Oncogene. 1991 Sep;6(9):1549–1553. [PubMed] [Google Scholar]
  30. Jonat C., Rahmsdorf H. J., Park K. K., Cato A. C., Gebel S., Ponta H., Herrlich P. Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell. 1990 Sep 21;62(6):1189–1204. doi: 10.1016/0092-8674(90)90395-u. [DOI] [PubMed] [Google Scholar]
  31. Kaneda T., Murate T., Sheffery M., Brown K., Rifkind R. A., Marks P. A. Gene expression during terminal differentiation: dexamethasone suppression of inducer-mediated alpha 1- and beta maj-globin gene expression. Proc Natl Acad Sci U S A. 1985 Aug;82(15):5020–5024. doi: 10.1073/pnas.82.15.5020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mangelsdorf D. J., Thummel C., Beato M., Herrlich P., Schütz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P. The nuclear receptor superfamily: the second decade. Cell. 1995 Dec 15;83(6):835–839. doi: 10.1016/0092-8674(95)90199-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Metz T. Oncogenes and erythroid differentiation. Semin Cancer Biol. 1994 Apr;5(2):125–135. [PubMed] [Google Scholar]
  34. Minie M., Clark D., Trainor C., Evans T., Reitman M., Hannon R., Gould H., Felsenfeld G. Developmental regulation of globin gene expression. J Cell Sci Suppl. 1992;16:15–20. doi: 10.1242/jcs.1992.supplement_16.3. [DOI] [PubMed] [Google Scholar]
  35. Muchardt C., Yaniv M. A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J. 1993 Nov;12(11):4279–4290. doi: 10.1002/j.1460-2075.1993.tb06112.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Muller M., Renkawitz R. The glucocorticoid receptor. Biochim Biophys Acta. 1991 Feb 16;1088(2):171–182. doi: 10.1016/0167-4781(91)90052-n. [DOI] [PubMed] [Google Scholar]
  37. Pain B., Woods C. M., Saez J., Flickinger T., Raines M., Peyrol S., Moscovici C., Moscovici M. G., Kung H. J., Jurdic P. EGF-R as a hemopoietic growth factor receptor: the c-erbB product is present in chicken erythrocytic progenitors and controls their self-renewal. Cell. 1991 Apr 5;65(1):37–46. doi: 10.1016/0092-8674(91)90405-n. [DOI] [PubMed] [Google Scholar]
  38. Patel V. P., Lodish H. F. A fibronectin matrix is required for differentiation of murine erythroleukemia cells into reticulocytes. J Cell Biol. 1987 Dec;105(6 Pt 2):3105–3118. doi: 10.1083/jcb.105.6.3105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rolink A., Melchers F. Molecular and cellular origins of B lymphocyte diversity. Cell. 1991 Sep 20;66(6):1081–1094. doi: 10.1016/0092-8674(91)90032-t. [DOI] [PubMed] [Google Scholar]
  40. Sap J., Muñoz A., Damm K., Goldberg Y., Ghysdael J., Leutz A., Beug H., Vennström B. The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature. 1986 Dec 18;324(6098):635–640. doi: 10.1038/324635a0. [DOI] [PubMed] [Google Scholar]
  41. Schroeder C., Gibson L., Nordström C., Beug H. The estrogen receptor cooperates with the TGF alpha receptor (c-erbB) in regulation of chicken erythroid progenitor self-renewal. EMBO J. 1993 Mar;12(3):951–960. doi: 10.1002/j.1460-2075.1993.tb05736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Schroeder C., Gibson L., Zenke M., Beug H. Modulation of normal erythroid differentiation by the endogenous thyroid hormone and retinoic acid receptors: a possible target for v-erbA oncogene action. Oncogene. 1992 Feb;7(2):217–227. [PubMed] [Google Scholar]
  43. Smarda J., Sugarman J., Glass C., Lipsick J. Retinoic acid receptor alpha suppresses transformation by v-myb. Mol Cell Biol. 1995 May;15(5):2474–2481. doi: 10.1128/mcb.15.5.2474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Smit-McBride Z., Privalsky M. L. DNA sequence specificity of the v-erb A oncoprotein/thyroid hormone receptor: role of the P-box and its interaction with more N-terminal determinants of DNA recognition. Mol Endocrinol. 1994 Jul;8(7):819–828. doi: 10.1210/mend.8.7.7984144. [DOI] [PubMed] [Google Scholar]
  45. Steinlein P., Deiner E., Leutz A., Beug H. Recombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitro. Growth Factors. 1994;10(1):1–16. doi: 10.3109/08977199409019599. [DOI] [PubMed] [Google Scholar]
  46. Steinlein P., Wessely O., Meyer S., Deiner E. M., Hayman M. J., Beug H. Primary, self-renewing erythroid progenitors develop through activation of both tyrosine kinase and steroid hormone receptors. Curr Biol. 1995 Feb 1;5(2):191–204. doi: 10.1016/s0960-9822(95)00040-6. [DOI] [PubMed] [Google Scholar]
  47. Thompson M. A., Ramsay R. G. Myb: an old oncoprotein with new roles. Bioessays. 1995 Apr;17(4):341–350. doi: 10.1002/bies.950170410. [DOI] [PubMed] [Google Scholar]
  48. Tsai M. J., O'Malley B. W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem. 1994;63:451–486. doi: 10.1146/annurev.bi.63.070194.002315. [DOI] [PubMed] [Google Scholar]
  49. Tsiftsoglou A., Housman D., Wong W. The inhibition of commitment of mouse erythroleukemia cells by steroids involves a glucocorticoid-receptor mediated process(es) acting at the nuclear level. Biochim Biophys Acta. 1986 Nov 28;889(2):251–261. doi: 10.1016/0167-4889(86)90111-4. [DOI] [PubMed] [Google Scholar]
  50. Udupa K. B., Crabtree H. M., Lipschitz D. A. In vitro culture of proerythroblasts: characterization of proliferative response to erythropoietin and steroids. Br J Haematol. 1986 Apr;62(4):705–714. doi: 10.1111/j.1365-2141.1986.tb04094.x. [DOI] [PubMed] [Google Scholar]
  51. Weber B. L., Westin E. H., Clarke M. F. Differentiation of mouse erythroleukemia cells enhanced by alternatively spliced c-myb mRNA. Science. 1990 Sep 14;249(4974):1291–1293. doi: 10.1126/science.2205003. [DOI] [PubMed] [Google Scholar]
  52. White R., Lees J. A., Needham M., Ham J., Parker M. Structural organization and expression of the mouse estrogen receptor. Mol Endocrinol. 1987 Oct;1(10):735–744. doi: 10.1210/mend-1-10-735. [DOI] [PubMed] [Google Scholar]
  53. Yoshinaga S. K., Peterson C. L., Herskowitz I., Yamamoto K. R. Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science. 1992 Dec 4;258(5088):1598–1604. doi: 10.1126/science.1360703. [DOI] [PubMed] [Google Scholar]
  54. Zenke M., Muñoz A., Sap J., Vennström B., Beug H. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA. Cell. 1990 Jun 15;61(6):1035–1049. doi: 10.1016/0092-8674(90)90068-p. [DOI] [PubMed] [Google Scholar]
  55. Zitnik G., Peterson K., Stamatoyannopoulos G., Papayannopoulou T. Effects of butyrate and glucocorticoids on gamma- to beta-globin gene switching in somatic cell hybrids. Mol Cell Biol. 1995 Feb;15(2):790–795. doi: 10.1128/mcb.15.2.790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Zito G. E., Lynch E. C. Prednisone-responsive congenital erythroid hypoplasia. JAMA. 1977 Mar 7;237(10):991–992. [PubMed] [Google Scholar]

Articles from The EMBO Journal are provided here courtesy of Nature Publishing Group

RESOURCES